News About: Pharm. Affairs
Will Cyramza with health insurance benefits broaden options for stomach cancer patients?
Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients?
Lilly Korea, on th...
Increase in OTC drug approval
The number of OTC drug approvals has increased since this year. The percentage of approvals for OTC drugs is reaching 27% by this April.
According to the Ministry of Food and Drug Safety(MFDS) Online Library, there w...
Pharmas active in developing antihypertensive combination drugs
Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension.
Moreover, antihypertensives are reportedly moving towards a trend with...
“In Korean CSO market are about 4 thousand private business owners”
“The number of private business owners is estimated at approximately 3 to 4 thousand in the Korean pharmaceutical market. Some think in the market are over 20 thousand business owners. In order for the Korean CSO mark...
TYLENOL may cause liver damages if taking more than 4,000mg a day
It was studied that drugs containing acetaminophen, such as analgesic/antipyretic TYLENOL, had a high chance to cause liver damages if being taken by patients with a volume higher than 4,000mg a day.
Thus, approval d...
Hanmi Pharm’s innovative anticancer drug ‘Posiotinib’ published in international SCI journal
A research result of Poziotinib, a targeted therapy for cancer developed by Hanmi Pharm, was registered in the online version of Nature Medicine, an international SCI(Science Citation Index) journal.
Spectrum Pharmac...
Prostatic cancer treatments ‘Jevtana’ and ‘Zytiga’ newly registered in list of health insurance benefits this May
104 products, such as Jevtana and Zytiga, prostate cancer therapies, will be newly registered in the list of health insurance benefits this May.
The Ministry of Health and Welfare(MOHW) revised and placed the ‘Drug I...
59% of members in KPA were women pharmacists
While the ratio of women pharmacists is getting higher and higher, 59% of members in the Korea Pharmaceutical Association(KPA) reportedly were female pharmacists.
According to the Korea Pharmaceutical Association Sta...
Psoriatic arthritis therapy ‘Guselkumab’ acquires approval in Korea
‘Guselkumab(product name: Tremfya Prefilled Syringe Inj),’ a Janssen’s psoriasis & arthritis therapy, acquired approval in Korea.
The Ministry of Food and Drug Safety(MFDS) decided new drug approval on ‘Tremfya Prefi...
Which are new drugs approved this 1st quarter?
4 new drugs including ‘Aljaview Inj,’ a FutureChem’s diagnostic drug for Alzheimer’s disease, reportedly acquire approval in the last 1st quarter.
According to the Ministry of Food and Drug Safety’s Online Drug Libra...
